Karen O’Dwyer

562 total citations
12 papers, 456 citations indexed

About

Karen O’Dwyer is a scholar working on Molecular Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Karen O’Dwyer has authored 12 papers receiving a total of 456 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Medicine, 5 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Karen O’Dwyer's work include Antibiotic Resistance in Bacteria (6 papers), Peptidase Inhibition and Analysis (5 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). Karen O’Dwyer is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Peptidase Inhibition and Analysis (5 papers) and Antimicrobial Resistance in Staphylococcus (3 papers). Karen O’Dwyer collaborates with scholars based in United States, United Kingdom and France. Karen O’Dwyer's co-authors include Magdalena Zalacaín, David Holmes, Karen Ingraham, Leslie M. Palmer, Michael A. Lonetto, James R. Brown, Pan F. Chan, Martin Rosenberg, Christine L. Willis and D. Warren Spence and has published in prestigious journals such as Scientific Reports, Journal of Bacteriology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Karen O’Dwyer

12 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Karen O’Dwyer United States	9	274	97	96	76	76	12	456
Vladimir Vimberg Czechia	12	313 1.1×	59 0.6×	40 0.4×	64 0.8×	72 0.9×	21	473
Svetlana Dubiley Russia	17	460 1.7×	93 1.0×	166 1.7×	105 1.4×	60 0.8×	38	736
Nathalie Josseaume France	12	274 1.0×	74 0.8×	50 0.5×	167 2.2×	101 1.3×	17	517
Carole Veckerlé France	7	158 0.6×	154 1.6×	46 0.5×	135 1.8×	129 1.7×	9	387
Xinwei Sher United States	8	260 0.9×	62 0.6×	36 0.4×	149 2.0×	46 0.6×	9	430
Kwang Hoon Sung South Korea	8	227 0.8×	33 0.3×	84 0.9×	45 0.6×	166 2.2×	12	393
Kedar Purnapatre India	14	384 1.4×	89 0.9×	29 0.3×	89 1.2×	51 0.7×	25	548
Jitender Mehla United States	13	241 0.9×	58 0.6×	27 0.3×	49 0.6×	79 1.0×	21	426
Lorenza Favrot United States	7	255 0.9×	106 1.1×	42 0.4×	126 1.7×	33 0.4×	9	408
Beatriz Llano-Sotelo United States	7	334 1.2×	61 0.6×	50 0.5×	68 0.9×	115 1.5×	8	473

Countries citing papers authored by Karen O’Dwyer

Since Specialization

Citations

This map shows the geographic impact of Karen O’Dwyer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen O’Dwyer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen O’Dwyer more than expected).

Fields of papers citing papers by Karen O’Dwyer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen O’Dwyer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen O’Dwyer. The network helps show where Karen O’Dwyer may publish in the future.

Co-authorship network of co-authors of Karen O’Dwyer

This figure shows the co-authorship network connecting the top 25 collaborators of Karen O’Dwyer. A scholar is included among the top collaborators of Karen O’Dwyer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen O’Dwyer. Karen O’Dwyer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Hilliard, Jamese J., Charles Jakielaszek, Frank Mannino, et al.. (2024). Efficacy of therapeutically administered gepotidacin in a rabbit model of inhalational anthrax. Antimicrobial Agents and Chemotherapy. 68(3). e0149723–e0149723. 2 indexed citations

Jakielaszek, Charles, Jamese J. Hilliard, Frank Mannino, et al.. (2023). Efficacy of Intravenously Administered Gepotidacin in Cynomolgus Macaques following a Francisella tularensis Inhalational Challenge. Antimicrobial Agents and Chemotherapy. 67(5). e0138122–e0138122. 6 indexed citations

Jakielaszek, Charles, Mohammad Sharif Hossain, Lian Qian, et al.. (2022). Gepotidacin is efficacious in a nonhuman primate model of pneumonic plague. Science Translational Medicine. 14(647). eabg1787–eabg1787. 9 indexed citations

Bailey, Andy M., Fabrizio Alberti, Sreedhar Kilaru, et al.. (2016). Identification and manipulation of the pleuromutilin gene cluster from Clitopilus passeckerianus for increased rapid antibiotic production. Scientific Reports. 6(1). 25202–25202. 76 indexed citations

Ingraham, Karen, Jianzhong Huang, Lynn McCloskey, et al.. (2015). Frequency of Spontaneous Resistance to Peptide Deformylase Inhibitor GSK1322322 in Haemophilus influenzae, Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy. 59(8). 4644–4652. 5 indexed citations

O’Dwyer, Karen, Aaron Spivak, Karen Ingraham, et al.. (2014). Bacterial Resistance to Leucyl-tRNA Synthetase Inhibitor GSK2251052 Develops during Treatment of Complicated Urinary Tract Infections. Antimicrobial Agents and Chemotherapy. 59(1). 289–298. 73 indexed citations

O’Dwyer, Karen, et al.. (2013). Comparative Analysis of the Antibacterial Activity of a Novel Peptide Deformylase Inhibitor, GSK1322322. Antimicrobial Agents and Chemotherapy. 57(5). 2333–2342. 34 indexed citations

O’Dwyer, Karen, et al.. (2013). Potent Sub-MIC Effect of GSK1322322 and Other Peptide Deformylase Inhibitors on In Vitro Growth of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 58(1). 290–296. 14 indexed citations

O’Dwyer, Karen, Joseph Watts, Michael Barber, et al.. (2004). Characterization of Streptococcus pneumoniae TrmD, a tRNA Methyltransferase Essential for Growth. Journal of Bacteriology. 186(8). 2346–2354. 39 indexed citations

10.

Zalacaín, Magdalena, Karen Ingraham, Alexander P. Bryant, et al.. (2003). A Global Approach to Identify Novel Broad-Spectrum Antibacterial Targets among Proteins of Unknown Function. Microbial Physiology. 6(2). 109–126. 72 indexed citations

11.

Bruton, Gordon, Anthony Huxley, Peter J. O’Hanlon, et al.. (2003). Lipopeptide substrates for SpsB, the Staphylococcus aureus type I signal peptidase: design, conformation and conversion to α-ketoamide inhibitors. European Journal of Medicinal Chemistry. 38(4). 351–356. 47 indexed citations

12.

Chan, Pan F., Karen O’Dwyer, Leslie M. Palmer, et al.. (2003). Characterization of a Novel Fucose-Regulated Promoter (P_fcsK) Suitable for Gene Essentiality and Antibacterial Mode-of-Action Studies inStreptococcus pneumoniae. Journal of Bacteriology. 185(6). 2051–2058. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact